citalopram and semaglutide Is there a clinically significant drug‑drug interaction between (GLP‑1 receptor agonist) lamotrigine (Lamictal)? Semaglutide - PRAMAH / THE

The emerging data on GLP-1 receptor agonists and neurodegeneration adds another dimension

Intravenous N-acetylcysteine is associated with fewer of the adverse effects seen with the oral preparation, such as nausea, vomiting, abdominal pain, diarrhea and rash, but it carries a higher risk of anaphylactoid reactions.9 When patients present relatively late after ingestion, oral N-acetylcysteine protocols provide a higher dose given over a longer period, which may be an advantage.2 , 10 However, the gastrointestinal adverse effects associated with oral therapy are a substantial disadvantage, notably if this results in a longer time for drug absorption and hence a longer time to reach therapeutic effect.2 Since the introduction and adoption of routine use of N-acetylcysteine therapy, the mortality rate in acetaminophen overdose has declined from 3% to 0.7%.11 Prevention of overdose and medication errors in children This report highlights the issue of accurate dosing in pediatrics

We don't just focus on weight loss

Many people report feeling full after just a few bites, losing interest in food, or developing aversions to foods they once enjoyed